Upon arriving last July at the facility, the FDA inspectors initially saw Microsoft Excel documents on a desktop computer in a production office. But the next day, the files — some of which pertained ...
Recent federal developments may soon require cosmetic companies to adopt stringent precautions to ensure that talc-containing ...
The U.K. biopharmaceutical company said data from a Phase 2 study of eRapa, a treatment for familial adenomatous polyposis, showed the drug to be safe and well-tolerated among users. The treatment ...
Immix Biopharma (IMMX) announced that the U.S. FDA has granted RMAT designation to sterically-optimized CAR-T NXC-201 for the treatment of ...
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous PolyposisUnderscores unmet need for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results